Erythromelalgia presenting as recurrent purpura and hypogammaglobulinemia: A case report
-
- Karasawa Takao
- Department of Pediatrics, Hirosaki University Hospital Department of Vascular Biology, Hirosaki University Graduate School of Medicine
-
- Hashimoto Shun
- Department of Pediatrics, Hirosaki University Hospital
-
- Sato Riko
- Department of Pediatrics, Hirosaki University Hospital
-
- Fujita Masashi
- Department of Pediatrics, Hirosaki University Hospital
-
- Aizawa Tomomi
- Department of Pediatrics, Hirosaki University Hospital
-
- Tsugawa Koji
- Department of Pediatrics, Hirosaki University Hospital
-
- Toki Tsutomu
- Department of Pediatrics, Hirosaki University Graduate School of Medicine
-
- Kanezaki Rika
- Department of Pediatrics, Hirosaki University Graduate School of Medicine
-
- Sato Tomohiko
- Department of Pediatrics, Hirosaki University Hospital
-
- Kudo Ko
- Department of Pediatrics, Hirosaki University Hospital
-
- Terui Kiminori
- Department of Pediatrics, Hirosaki University Hospital Department of Pediatrics, Hirosaki University Graduate School of Medicine
-
- Tanaka Hiroshi
- Department of Pediatrics, Hirosaki University Hospital Department of School Health Science, Hirosaki University Faculty of Education
Bibliographic Information
- Other Title
-
- 長期に渡る繰り返す紫斑と低γグロブリン血症を主症状とした肢端紅痛症
- チョウキ ニ ワタル クリカエス シハン ト テイgグロブリン ケッショウ オ シュ ショウジョウ ト シタ シタンコウツウショウ
Search this article
Abstract
Erythromelalgia is a rare clinical entity that manifests as redness, heat, and burning pain in the extremities. The causative gene for erythromelalgia, SCN9A, encodes a voltage-gated sodium channel, subtype Nav1.7. We report a case of a 26-year-old woman with erythromelalgia. She had 15-year history of recurrent purpura and swelling in the lower extremities. At 16 years of age, she was diagnosed with skin biopsy-proven leukocytoclastic vasculitis associated with unexpected hypogammaglobulinemia (IgG 320 mg/dL, IgA 12 mg/dL, IgM 35 mg/dL). Under the tentative diagnosis of refractory IgA vasculitis, she was treated with prednisolone and intravenous immunoglobulin administration. However, the therapeutic intervention was only partially effective. Because of an atypical clinical course of IgA vasculitis, a genetic analysis for erythromelalgia was conducted when at 25 years of age, which revealed a pathogenetic mutation in the SCN9A gene. Her mother also had the same mutation. After the diagnosis of erythromelalgia, carbamazepine administration was initiated and the treatment was successful. Unusual clinical manifestations of refractory purpura and hypogammaglobulinemia sometimes occur in selected patients with erythromelalgia. This case may contribute to the expansion of phenotypic presentation of erythromelalgia.
Journal
-
- Hirosaki Medical Journal
-
Hirosaki Medical Journal 72 (1-4), 80-83, 2022
Hirosaki University Graduate School of Medicine,Hirosaki Medical Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390010292800400000
-
- NII Book ID
- AN00211444
-
- ISSN
- 24344656
- 04391721
-
- HANDLE
- 10129/00007787
-
- NDL BIB ID
- 032111555
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- IRDB
- NDL
-
- Abstract License Flag
- Disallowed